Copyright
©The Author(s) 2024.
World J Crit Care Med. Mar 9, 2024; 13(1): 89085
Published online Mar 9, 2024. doi: 10.5492/wjccm.v13.i1.89085
Published online Mar 9, 2024. doi: 10.5492/wjccm.v13.i1.89085
Data | Non CRBSI (n = 126) | CRBSI (n = 10) | P value (CRBSI vs non) |
Time of CVC (d) [median (p 25-75)] | 9 (7-12) | 12 (10-18) | 0.02 |
Site of CVC, n (%) | 0.19 | ||
Subclavian | 28 (22.2) | 3 (30.0) | |
Jugular | 62 (49.2) | 2 (50.0) | |
Femoral | 36 (28.6) | 5 (50.0) | |
Age (yr, p 25-75) | 65 (57-70) | 65 (58-75) | 0.50 |
Sex female, n (%) | 30 (23.8) | 1 (10.0) | 0.45 |
Admission diagnostic, n (%) | 0.74 | ||
Medical | 73 (57.9) | 7 (70.0) | |
Surgical | 39 (31.0) | 2 (20.0) | |
Traumatology | 14 (11.1) | 1 (10.0) | |
Diabetes mellitus, n (%) | 39 (31.0) | 3 (30.0) | 0.99 |
COPD, n (%) | 16 (12.7) | 0 | 0.61 |
Asthma, n (%) | 3 (2.4) | 0 | 0.99 |
Chronic liver disease, n (%) | 25 (19.8) | 0 | 0.21 |
Smoking, n (%) | 36 (28.6) | 4 (40.0) | 0.48 |
Hematological tumor, n (%) | 2 (1.6) | 0 | 0.99 |
Solid tumor, n (%) | 15 (11.9) | 2 (20.0) | 0.61 |
Human immunodeficiency virus, n (%) | 1 (0.8) | 0 | 0.99 |
Renal replacement previously to ICU admission, n (%) | 17 (13.5) | 1 (10.0) | 0.99 |
Corticosteroids previously to ICU admission, n (%) | 14 (11.1) | 1 (10.0) | 0.99 |
Immunosuppressants previously to ICU admission, n (%) | 10 (7.9) | 1 (10.0) | 0.58 |
Corticosteroids at CRI suspicion, n (%) | 44 (34.9) | 4 (40.0) | 0.74 |
Parenteral nutrition at CRI suspicion, n (%) | 17 (13.5) | 3 (30.0) | 0.17 |
Propofol at CRI suspicion, n (%) | 69 (54.8) | 8 (80.0) | 0.19 |
Deaths at 30 d of CRI suspicion, n (%) | 9 (7.1) | 0 | 0.99 |
Maki + | Maki - | Total | |
Vortex + | 18 | 0 | 18 |
Vortex - | 3 | 115 | 118 |
Total | 21 | 115 | 136 |
Maki + | Maki - | Total | |
Vortex + | 9 | 0 | 9 |
Vortex - | 1 | 126 | 127 |
Total | 10 | 126 | 136 |
- Citation: Lorente L, Lecuona Fernandez M, González-Mesa A, Oliveras-Roura J, Rosado C, Cabrera P, Casal E, Jiménez A, Mora ML, Madueño A. Adding vortexing to the Maki technique provides no benefit for the diagnosis of catheter colonization or catheter-related bacteremia. World J Crit Care Med 2024; 13(1): 89085
- URL: https://www.wjgnet.com/2220-3141/full/v13/i1/89085.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v13.i1.89085